Stock listing
ALJXR Stock Price, News, Filings & Events — Archos Sa
Selected listing: ALJXR · EURONEXT · EUR · FR
This page tracks Archos Sa's ALJXR:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALJXR:EURONEXT. ALJXR:EURONEXT is the stock-level entry point for investors researching Archos Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Archos Sa is a public company listed on the French market under the ticker ALJXR, with a market capitalization of approximately €16.27 million. The company focuses on technology and innovation, offering a range of products and services. Archos Sa aims to enhance user experiences through its advancements in the tech industry.
- Ticker
- ALJXR:EURONEXT
- Asset type
- Stock
- Market cap
- $19.3M
- Sector
- Electronic Technology
- Industry
- Computer Processing Hardware
- Exchange
- EURONEXT
- Currency
- EUR
Archos Sa ALJXR:EURONEXT stock context
This page tracks Archos Sa's ALJXR:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALJXR:EURONEXT. ALJXR:EURONEXT is the stock-level entry point for investors researching Archos Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Archos Sa is a public company listed on the French market under the ticker ALJXR, with a market capitalization of approximately €16.27 million. The company focuses on technology and innovation, offering a range of products and services. Archos Sa aims to enhance user experiences through its advancements in the tech industry.
Latest news from Archos Sa
Archos : 2026-2027 Strategic Roadmap for the Logic Instrument Group, a subsidiary of ARCHOS, and update to date
November 19, 2025
ARCHOS: Turnover up 28% and operating profit up 360%
August 7, 2025
ARCHOS: Strong Revenue Growth of 27% in the First Half of 2025
July 17, 2025
ARCHOS: Offer to acquire 100% of O2I Ingénierie shares
May 26, 2025
Archos : LOGIC INSTRUMENT, a subsidiary of ARCHOS, announces the acquisition of 100% of GLACIER COMPUTER LLC, USA
March 24, 2025
Research Archos Sa
Archos Sa investor report
Review AI stock analysis and investor report context for ALJXR:EURONEXT.
Archos Sa company profile
View the public company page for Archos Sa on 6ix.
Archos Sa news
Read company news and market updates connected to Archos Sa.
Archos Sa investor events
Find investor webinars, events, and replay context for Archos Sa.
Alternate listings
0OI0:LSE
GB · EUR
Alternate listing for Archos Sa; the primary context on this page is ALJXR:EURONEXT.
A3EUNY:LSX
DE · EUR
Alternate listing for Archos Sa; the primary context on this page is ALJXR:EURONEXT.
AYH:GETTEX
DE · EUR
Alternate listing for Archos Sa; the primary context on this page is ALJXR:EURONEXT.
A3EUNY:LS
DE · EUR
Alternate listing for Archos Sa; the primary context on this page is ALJXR:EURONEXT.
AYH:FWB
DE · EUR
Alternate listing for Archos Sa; the primary context on this page is ALJXR:EURONEXT.
AYH:HAM
DE · EUR
Alternate listing for Archos Sa; the primary context on this page is ALJXR:EURONEXT.
AYH:SWB
DE · EUR
Alternate listing for Archos Sa; the primary context on this page is ALJXR:EURONEXT.
AYH:MUN
DE · EUR
Alternate listing for Archos Sa; the primary context on this page is ALJXR:EURONEXT.
ALJXRP:TURQUOISE
GB · EUR
Alternate listing for Archos Sa; the primary context on this page is ALJXR:EURONEXT.